This compound, TCI R0129 944450-43-5 RuCl2[(R)-dm-segphos(regR)][(R)-daipen], is a complex chiral catalyst used in asymmetric synthesis. It plays a crucial role in laboratories where precise control over reaction outcomes is essential, particularly in reactions requiring enantioselectivity. The compound is designed to facilitate the formation of chiral products with high stereochemical control, making it a valuable tool in synthetic chemistry. Its chiral ligand components are integral in directing chemical reactions toward specific asymmetric structures, enhancing the efficiency of synthesis processes.
The compound's unique properties make it a preferred choice for researchers working in asymmetric catalysis. Its chiral structure enables selective reaction pathways, reducing the need for additional purification steps and increasing overall yield. Additionally, it exhibits stability under controlled laboratory conditions, ensuring consistent performance across multiple experiments. This stability, combined with its ability to catalyze complex reactions, makes it a reliable reagent for advanced synthetic applications.
In Indonesian laboratories, this compound is commonly used in organic chemistry research, particularly in asymmetric synthesis and the development of bioactive compounds. Researchers in academic and industrial settings rely on its performance to achieve high-quality results in their experiments. Its application is widespread in pharmaceutical and chemical research, where precise stereochemical control is critical for producing active pharmaceutical ingredients.
TCI brochures (PDF)
- Ruthenium Complex Catalysts for Asymmetric Hydrogenation of Ketons 2024-12-16 · p. 2
- Hydrogenation Catalysts 2025-11-10 · p. 7
Related TCI products
- TCI R0128 944450-44-6 RuCl2[(S)-dm-segphos(regR)][(S)-daipen]
- TCI R0133 220114-32-9 RuCl2[(R)-xylbinap][(R)-daipen]
- TCI R0132 220114-01-2 RuCl2[(S)-xylbinap][(S)-daipen]
- TCI R0159 944451-33-6 [RuCl(p-cymene)((S)-dtbm-segphos(regR))]Cl
- TCI R0155 944451-29-0 [RuCl(p-cymene)((S)-segphos(regR))]Cl
- TCI R0154 944451-28-9 [RuCl(p-cymene)((R)-segphos(regR))]Cl
- Asymmetric Synthesis: This compound is ideal for asymmetric synthesis due to its chiral ligand structure, which enables precise enantioselective reactions.
- Pharmaceutical Research: It is widely used in pharmaceutical research to produce bioactive compounds with specific stereochemistry, essential for drug development.
- Organic Chemistry Studies: Its role in organic chemistry studies is significant, especially in creating complex molecules with controlled stereochemistry.
- Chiral Catalyst Development: It is a preferred catalyst in the development of new chiral catalysts, offering high efficiency and selectivity in synthetic reactions.
- Bioactive Compound Synthesis: Its ability to direct reactions toward specific products makes it valuable in the synthesis of compounds with biological activity.
| Brand | TCI |
|---|---|
| CAS number | 944450-43-5 |
| Molecular formula | — |
| Purity | — |
| Category | Chemistry > Asymmetric Synthesis > Chiral Catalysts, Chiral Ligands, Chiral Reagents |
| Pack sizes | Available in various pack sizes as per supplier specifications |
| Physical form | Solid or powder, depending on the formulation |
| Storage | Store in a cool, dry place away from moisture and light |
This compound should be stored in a cool, dry environment to maintain its stability and effectiveness. It is recommended to use airtight containers to prevent exposure to moisture and air, which could degrade its properties. Due to its chemical nature, it should be handled in a well-ventilated area, and appropriate personal protective equipment should be worn. Avoid contact with incompatible substances to ensure safety during handling and storage. Regular inspection of storage conditions is advised to ensure optimal performance and safety in laboratory settings.
References cited in the TCI brochure
- Cheng-yi Chen. Concise Asymmetric Synthesis of (+)-Conocarpan and Obtusafuran Synlett, 2012. doi:10.1055/s-0032-1317704
Product Categories
- Asymmetric SynthesisChiral Catalysts, Chiral Ligands, Chiral ReagentsHydrogenation [Asymmetric Synthesis]
- Catalysis and Inorganic ChemistryHydrogenation [Catalysis]Asymmetric Hydrogenation Catalysts
- Catalysis and Inorganic ChemistryTransition Elements [Catalysis and Inorganic Chemistry]Ruthenium [Catalysis and Inorganic Chemistry]
![944450-43-5 RuCl2[(R)-dm-segphos(regR)][(R)-daipen] - AMI Scientific](http://amiscientific.com/cdn/shop/files/TCI2510R0129.jpg?v=1767137921&width=1445)
![944450-44-6 RuCl2[(S)-dm-segphos(regR)][(S)-daipen] - AMI Scientific](http://amiscientific.com/cdn/shop/files/TCI2510R0128.jpg?v=1767137917&width=533)
![220114-32-9 RuCl2[(R)-xylbinap][(R)-daipen] - AMI Scientific](http://amiscientific.com/cdn/shop/files/TCI2510R0133.jpg?v=1767137936&width=533)
![220114-01-2 RuCl2[(S)-xylbinap][(S)-daipen] - AMI Scientific](http://amiscientific.com/cdn/shop/files/TCI2510R0132.jpg?v=1767137932&width=533)
![944451-33-6 [RuCl(p-cymene)((S)-dtbm-segphos(regR))]Cl - AMI Scientific](http://amiscientific.com/cdn/shop/files/TCI2510R0159.jpg?v=1767137989&width=533)
![944451-29-0 [RuCl(p-cymene)((S)-segphos(regR))]Cl - AMI Scientific](http://amiscientific.com/cdn/shop/files/TCI2510R0155.jpg?v=1767137981&width=533)
![944451-28-9 [RuCl(p-cymene)((R)-segphos(regR))]Cl - AMI Scientific](http://amiscientific.com/cdn/shop/files/TCI2510R0154.jpg?v=1767137978&width=533)
![944450-45-7 RuCl2[(R)-dm-segphos(regR)][(R,R)-dpen] - AMI Scientific](http://amiscientific.com/cdn/shop/files/TCI2510R0131.jpg?v=1767137929&width=533)
![944450-46-8 RuCl2[(S)-dm-segphos(regR)][(S,S)-dpen] - AMI Scientific](http://amiscientific.com/cdn/shop/files/TCI2510R0130.jpg?v=1767137925&width=533)